Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.92 HKD | 0.00% | +2.22% | -59.47% |
Apr. 24 | Cstone Pharmaceuticals Logs Lower Loss for 2023, Shares Up By Nearly 5% | MT |
Apr. 23 | CStone Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 474
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 60 | 16-11-30 |
Jun Cheng
DFI | Director of Finance/CFO | 44 | 22-02-28 |
Ying Hua Zhang
COO | Chief Operating Officer | 44 | 16-07-31 |
Wei Cong Ni
SEC | Corporate Secretary | - | 18-07-31 |
Sanhu Wang
LAW | General Counsel | 53 | 19-05-31 |
Shirley Zhao
PRN | Corporate Officer/Principal | - | 19-12-05 |
Michael J. Choi
PRN | Corporate Officer/Principal | 53 | 21-04-30 |
Yin Kwan Ho
SEC | Corporate Secretary | 47 | 22-07-27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Edward Hu
BRD | Director/Board Member | 61 | 21-07-08 |
Wei Li
BRD | Director/Board Member | 52 | 18-09-30 |
Ting Yuk Wu
BRD | Director/Board Member | 69 | 19-02-13 |
Hong Bin Sun
BRD | Director/Board Member | 48 | 19-02-13 |
Director/Board Member | 72 | 19-02-13 | |
Xiang Hong Lin
BRD | Director/Board Member | 53 | 20-11-29 |
Jian Xin Yang
CEO | Chief Executive Officer | 60 | 16-11-30 |
Kenneth Hitchner
BRD | Director/Board Member | 63 | 21-12-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,284,191,212 | 676,090,722 ( 52.65 %) | 0 | 52.65 % |
Company contact information
CStone Pharmaceuticals Co. Ltd.
North Block Suzhou Industrial Park 218 Xinghu Street
200126, Shanghai
+86 512 8718 6550
http://www.cstonepharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.47% | 140M | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- 2616 Stock
- Company CStone Pharmaceuticals